BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 31342643)

  • 1. SHIPping out diabetes-Metformin, an old friend among new SHIP2 inhibitors.
    Lehtonen S
    Acta Physiol (Oxf); 2020 Jan; 228(1):e13349. PubMed ID: 31342643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity.
    Polianskyte-Prause Z; Tolvanen TA; Lindfors S; Dumont V; Van M; Wang H; Dash SN; Berg M; Naams JB; Hautala LC; Nisen H; Mirtti T; Groop PH; Wähälä K; Tienari J; Lehtonen S
    FASEB J; 2019 Feb; 33(2):2858-2869. PubMed ID: 30321069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity.
    Sasaoka T; Wada T; Tsuneki H
    Pharmacol Ther; 2006 Dec; 112(3):799-809. PubMed ID: 16842857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHIP2: an emerging target for the treatment of type 2 diabetes mellitus.
    Baumgartener JW
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):291-8. PubMed ID: 14683460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2.
    Dyson JM; Kong AM; Wiradjaja F; Astle MV; Gurung R; Mitchell CA
    Int J Biochem Cell Biol; 2005 Nov; 37(11):2260-5. PubMed ID: 15964236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2.
    Suwa A; Yamamoto T; Sawada A; Minoura K; Hosogai N; Tahara A; Kurama T; Shimokawa T; Aramori I
    Br J Pharmacol; 2009 Oct; 158(3):879-87. PubMed ID: 19694723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
    Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
    Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PolyMet-HA nanocomplexs regulates glucose uptake by inhibiting SHIP2 activity.
    Yuan X; Ding L; Diao J; Wen S; Xu C; Zhou L; Du A
    J Biomater Appl; 2021 Feb; 35(7):849-856. PubMed ID: 32741295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ebselen enhances insulin sensitivity and decreases oxidative stress by inhibiting SHIP2 and protects from inflammation in diabetic mice.
    Polianskyte-Prause Z; Tolvanen TA; Lindfors S; Kon K; Hautala LC; Wang H; Wada T; Tsuneki H; Sasaoka T; Lehtonen S
    Int J Biol Sci; 2022; 18(5):1852-1864. PubMed ID: 35342343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.
    Giuriato S; Pesesse X; Bodin S; Sasaki T; Viala C; Marion E; Penninger J; Schurmans S; Erneux C; Payrastre B
    Biochem J; 2003 Nov; 376(Pt 1):199-207. PubMed ID: 12885297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity.
    Vandeput F; Backers K; Villeret V; Pesesse X; Erneux C
    Cell Signal; 2006 Dec; 18(12):2193-9. PubMed ID: 16824732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of SRC homology 2-containing inositol 5'-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling.
    Kagawa S; Sasaoka T; Yaguchi S; Ishihara H; Tsuneki H; Murakami S; Fukui K; Wada T; Kobayashi S; Kimura I; Kobayashi M
    J Clin Endocrinol Metab; 2005 May; 90(5):2911-9. PubMed ID: 15687335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
    Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of SHIP2 Ser132 phosphorylation, its nuclear localization and stability.
    Elong Edimo W; Derua R; Janssens V; Nakamura T; Vanderwinden JM; Waelkens E; Erneux C
    Biochem J; 2011 Nov; 439(3):391-401. PubMed ID: 21770892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.
    Onnockx S; De Schutter J; Blockmans M; Xie J; Jacobs C; Vanderwinden JM; Erneux C; Pirson I
    J Cell Physiol; 2008 Jan; 214(1):260-72. PubMed ID: 17620296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single nucleotide polymorphisms on SHIP2 is associated with Type 2 diabetes mellitus in Chinese Han population.
    Hao YM; Liu QJ; Wang RY; Cao YP; Zhang Y; Zuo LF
    Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):129-37. PubMed ID: 25635986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling.
    Ishihara H; Sasaoka T; Hori H; Wada T; Hirai H; Haruta T; Langlois WJ; Kobayashi M
    Biochem Biophys Res Commun; 1999 Jun; 260(1):265-72. PubMed ID: 10381377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes.
    Sasaoka T; Hori H; Wada T; Ishiki M; Haruta T; Ishihara H; Kobayashi M
    Diabetologia; 2001 Oct; 44(10):1258-67. PubMed ID: 11692174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalization of prandial blood glucose and improvement of glucose tolerance by liver-specific inhibition of SH2 domain containing inositol phosphatase 2 (SHIP2) in diabetic KKAy mice: SHIP2 inhibition causes insulin-mimetic effects on glycogen metabolism, gluconeogenesis, and glycolysis.
    Grempler R; Zibrova D; Schoelch C; van Marle A; Rippmann JF; Redemann N
    Diabetes; 2007 Sep; 56(9):2235-41. PubMed ID: 17596404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SHIP2: Structure, Function and Inhibition.
    Thomas MP; Erneux C; Potter BV
    Chembiochem; 2017 Feb; 18(3):233-247. PubMed ID: 27907247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.